MedTrace Logo

Immune Responses After a Booster Immunisation With IXIARO® in Elderly Compared to Young Individuals.

NCT03971058 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 64

Last updated 2019-06-03

No results posted yet for this study

Summary

The aim of this study is to investigate the immune responses following a booster immunisation with the Japanese Encephalitis vaccine in elderly subjects (above 60 years of age) in comparison to a young study group.

Conditions

  • Japanese Encephalitis Vaccine

Interventions

BIOLOGICAL

IXIARO®- Japanese Encephalitis vaccine

Booster Immunisation With IXIARO®- Japanese Encephalitis vaccine

Sponsors & Collaborators

  • Valneva Austria GmbH

    collaborator INDUSTRY

  • Medical University of Vienna

    lead OTHER

Principal Investigators

  • Ursula Wiedermann-Schmidt, Univ Prof MD · Medical University of Vienna, ISPTM

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-03-01
Primary Completion
2020-12-31
Completion
2021-03-31

Countries

  • Austria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03971058 on ClinicalTrials.gov